These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35060248)

  • 1. Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction.
    Chandramouli C; Ting TW; Tromp J; Agarwal A; Svedlund S; Saraste A; Hage C; Tan RS; Beussink-Nelson L; Lagerström Fermer M; Gan LM; Lund L; Shah SJ; Lam CSP
    Eur J Heart Fail; 2022 Apr; 24(4):681-684. PubMed ID: 35060248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.
    Shah SJ; Lam CSP; Svedlund S; Saraste A; Hage C; Tan RS; Beussink-Nelson L; Ljung Faxén U; Fermer ML; Broberg MA; Gan LM; Lund LH
    Eur Heart J; 2018 Oct; 39(37):3439-3450. PubMed ID: 30165580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
    Rush CJ; Berry C; Oldroyd KG; Rocchiccioli JP; Lindsay MM; Touyz RM; Murphy CL; Ford TJ; Sidik N; McEntegart MB; Lang NN; Jhund PS; Campbell RT; McMurray JJV; Petrie MC
    JAMA Cardiol; 2021 Oct; 6(10):1130-1143. PubMed ID: 34160566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
    Jones E; Wei J; Nelson MD; Bakir M; Mehta PK; Shufelt C; Minissian M; Sharif B; Pepine CJ; Handberg E; Cook-Wiens G; Sopko G; Bairey Merz CN
    PLoS One; 2020; 15(12):e0243213. PubMed ID: 33270715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of coronary microvascular dysfunction (CMD) in heart failure with preserved ejection fraction (HFpEF): a systematic review and meta-analysis.
    Lin X; Wu G; Wang S; Huang J
    Heart Fail Rev; 2024 Mar; 29(2):405-416. PubMed ID: 37870703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS-HFpEF study.
    Venkateshvaran A; Faxen UL; Hage C; Michaëlsson E; Svedlund S; Saraste A; Beussink-Nelson L; Fermer ML; Gan LM; Tromp J; Lam CSP; Shah SJ; Lund LH
    Eur J Heart Fail; 2022 Dec; 24(12):2251-2260. PubMed ID: 36196462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction.
    Erhardsson M; Ljung Faxén U; Venkateshvaran A; Svedlund S; Saraste A; Lagerström Fermer M; Gan LM; Shah SJ; Tromp J; Sp Lam C; Lund LH; Hage C
    ESC Heart Fail; 2023 Dec; 10(6):3729-3734. PubMed ID: 37920127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.
    Sinha A; Rahman H; Webb A; Shah AM; Perera D
    Eur Heart J; 2021 Nov; 42(43):4431-4441. PubMed ID: 34529791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
    Dryer K; Gajjar M; Narang N; Lee M; Paul J; Shah AP; Nathan S; Butler J; Davidson CJ; Fearon WF; Shah SJ; Blair JEA
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1033-H1042. PubMed ID: 29424571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF Study.
    Hage C; Svedlund S; Saraste A; Faxén UL; Benson L; Fermer ML; Gan LM; Shah SJ; Lam CSP; Lund LH
    J Card Fail; 2020 Nov; 26(11):1016-1021. PubMed ID: 32846205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction.
    Ahmad A; Corban MT; Toya T; Verbrugge FH; Sara JD; Lerman LO; Borlaug BA; Lerman A
    Eur J Heart Fail; 2021 May; 23(5):765-772. PubMed ID: 32949186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?
    Sinha A; Rahman H; Perera D
    Curr Opin Cardiol; 2023 Nov; 38(6):521-526. PubMed ID: 37668191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction: Results From the PROMIS-HFpEF Study.
    Sanders-van Wijk S; Tromp J; Beussink-Nelson L; Hage C; Svedlund S; Saraste A; Swat SA; Sanchez C; Njoroge J; Tan RS; Fermer ML; Gan LM; Lund LH; Lam CSP; Shah SJ
    Circulation; 2020 Nov; 142(21):2029-2044. PubMed ID: 33034202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of Coronary Flow Reserve Evaluated by Phase Contrast Cine-Magnetic Resonance Imaging in Patients With Heart Failure With Preserved Ejection Fraction.
    Kato S; Saito N; Kirigaya H; Gyotoku D; Iinuma N; Kusakawa Y; Iguchi K; Nakachi T; Fukui K; Futaki M; Iwasawa T; Kimura K; Umemura S
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26908404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular magnetic resonance assessment of coronary flow reserve improves risk stratification in heart failure with preserved ejection fraction.
    Kato S; Fukui K; Kodama S; Azuma M; Nakayama N; Iwasawa T; Kimura K; Tamura K; Utsunomiya D
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):112. PubMed ID: 34657615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study.
    Eidizadeh A; Schnelle M; Leha A; Edelmann F; Nolte K; Werhahn SM; Binder L; Wachter R
    ESC Heart Fail; 2023 Feb; 10(1):200-210. PubMed ID: 36184749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta-analysis.
    D'Amario D; Laborante R; Bianchini E; Ciliberti G; Paglianiti DA; Galli M; Restivo A; Stolfo D; Vergallo R; Rosano GMC; Crea F; Lam CSP; Lund LH; Metra M; Patti G; Savarese G
    ESC Heart Fail; 2024 Aug; 11(4):2063-2075. PubMed ID: 38549197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M
    Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between coronary microvascular dysfunction, atrial fibrillation and heart failure with preserved ejection fraction.
    Ozcan C; Allan T; Besser SA; de la Pena A; Blair J
    Am J Cardiovasc Dis; 2021; 11(1):29-38. PubMed ID: 33815917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.